NCT06592716Active, not recruiting
Can Recurrence of Cancer in the Oropharynx be Detected by Blood Samples?
Specificity and Sensitivity of Circulating HPV-DNA in Patients With Oropharyngeal Squamous Cell Carcinoma
Source: ClinicalTrials.gov · Last updated 18 Nov 2025
Brief summary (registry, in English)
This study investigates if longitudinal analyses of cell-free HPV-DNA in blood samples can be utilized to detect recurrence in patients diagnosed and treated for HPV-positive oropharyngeal squamous cell carcinoma.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 6 Sept 2024
- Start date
- 2 Apr 2024
- Primary completion date
- 31 Dec 2028
- Lead sponsor
- Copenhagen University Hospital, Rigshospitalet
- Diseases
- Head and neck cancer
- NCT number
- NCT06592716
What you commit to
- Study type: Observational
- Planned participants: 200
- From 2 Apr 2024 to the primary completion date, 31 Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- The patient does not speak or understand Danish
- patients recieving palliative treatment
Who the study is looking for
- Patients with newly diagnosed HPV+ (and/or p16+) oropharyngeal squamous cell carcinoma
- Above 18 years of age
- Informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Otorhinolaryngology, Head and Neck Surgery and Audiology Coordinator of this site? Confirm its status | Copenhagen | Denmark | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.